Eli Lilly and Company Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: 17.10

Eli Lilly and Company Interest Coverage Ratio is 17.10 for the Trailing 12 Months (TTM) ending March 31, 2025, a 18.45% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Eli Lilly and Company Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was 14.44, a -23.92% change year over year.
  • Eli Lilly and Company Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was 18.98, a -9.60% change year over year.
  • Eli Lilly and Company Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was 20.99, a 0.92% change year over year.
  • Eli Lilly and Company Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was 20.80, a 27.75% change year over year.
Key Data
Date Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA)